Nagai, Nobuhiro Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats. [electronic resource] - International journal of pharmaceutics Aug 2019 - 118458 p. digital Publication Type: Journal Article ISSN: 1873-3476 Standard No.: 10.1016/j.ijpharm.2019.118458 doi Subjects--Topical Terms: Angiogenesis Inhibitors--administration & dosageAnimalsChitosan--administration & dosageChoroidal Neovascularization--drug therapyCollagen--administration & dosageDrug Implants--administration & dosageDrug LiberationEye--drug effectsFluorescein-5-isothiocyanate--administration & dosageGelatin--administration & dosageLasersMaleMethacrylates--administration & dosagePolyethylene Glycols--administration & dosageRanibizumab--administration & dosageRats, Sprague-DawleySerum Albumin--administration & dosage